Glucose
In clinical developmentAlso known as D(+)-Glucose, D-glucose, DEXTROSE, DEXTROSE, UNSPECIFIED FORM+57 more
D(+)-Glucose, D-glucose, DEXTROSE, DEXTROSE, UNSPECIFIED FORM, Dex4, Dex4 Assorted Fruit, Dex4 Berry Twist, Dex4 Citrus Punch, Dex4 Fruit Punch, Dex4 Grape, Dex4 Mango Twist, Dex4 Natural Orange, Dex4 Orange, Dex4 Raspberry, Dextrosa, Dextrose 5%, Dextrose 5% and Plasma-Lyte 148, Dextrose, unspecified, Emetrol, Emetrol for Nausea, Enfamil Glucose, GlucoBurst, Glucose Ophthalmic, Grape sugar, Insta-Glucose, Ionosol-MB, Isolyte P, Isolyte S and 5% Dextrose, Isolyte S in 5 % Dextrose, Monojel, Navstel, Normosol-M, Normosol-R and 5% Dextrose, Normosol-R in 5 % Dextrose, Plasma-Lyte 56 and 5% Dextrose, Plasma-Lyte 56 in 5 % Dextrose, ReliOn Glucose, Glucosa, Glutose, Clinimix 4.25/10, Clinimix 4.25/25, Clinimix 4.25/5, Clinimix 5/15, Clinimix 5/20, Clinimix 5/25, Clinimix E 2.75/5, Clinimix E 4.25/10, Clinimix E 4.25/5, Clinimix E 5/15, Clinimix E 5/20, Clinimix E 5/25, Dextrose Anhydrous, Dextrose Monohydrate, Dextrose and Potassium Chloride, Dextrose/Potassium Chloride/Sodium Chloride, Dianeal Low Calcium 1.5, Dianeal Low Calcium 2.5, Dianeal Low Calcium 4.25, Dianeal PD-2/1.5, Dianeal PD-2/2.5, Dianeal PD-2/4.25.
Recent clinical, regulatory, research and industry developments relating to this drug.
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
Researchers discover why fructose doesn't satisfy hunger like glucose
Researchers discover why fructose doesn't satisfy hunger like glucose
FDA clears Dexcom’s Stelo OTC glucose monitor for use with children
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Glycolytic reprogramming during microglial polarization in neurological diseases.
Exercise-induced signalling in alleviating neuronal insulin resistance.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences10
- Nature communications7
- The Journal of clinical investigation6
- Frontiers in endocrinology5
- Cardiovascular diabetology4
- Nutrients4
- Li Y3
- Müller TD3
- Nauck MA3
- Reimann F3
- Yang M3
- Zhang H3
- Ashrafi G2
- Bäckhed F2
- School of Medicine5
- German Center for Diabetes Research (DZD)3
- Institute for Diabetes and Obesity3
- Novo Nordisk Foundation Center for Basic Metabolic Research3
- Diabetes Center Bochum-Hattingen2
- Duke University Medical Center2
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 35 of the same disease areas as Glucose in the shared literature.
Studied across 16 of the same disease areas as Glucose in the shared literature.
Studied across 18 of the same disease areas as Glucose in the shared literature.
Studied across 16 of the same disease areas as Glucose in the shared literature.
Studied across 14 of the same disease areas as Glucose in the shared literature.
Studied across 9 of the same disease areas as Glucose in the shared literature.
Studied across 10 of the same disease areas as Glucose in the shared literature.
Studied across 10 of the same disease areas as Glucose in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials